Researchers are Gaining a Better Understanding of Disease Development at the Cellular Level

  The University of Southern California (USC) recently published an article in USC News announcing that researchers have discovered a technique allowing them to untangle the coiled, spiraling DNA molecules.…

Continue Reading Researchers are Gaining a Better Understanding of Disease Development at the Cellular Level
An Oklahoma Medical Research Foundation Scientist Played a Critical Role in Developing a New Sickle Cell Disease Treatment
source: pixabay.com

An Oklahoma Medical Research Foundation Scientist Played a Critical Role in Developing a New Sickle Cell Disease Treatment

According to a story from The Oklahoman, Dr. Roger McEver, who is a scientist and the Vice President of Research at the Oklahoma Medical Research Foundation (OMRF), played a pioneering…

Continue Reading An Oklahoma Medical Research Foundation Scientist Played a Critical Role in Developing a New Sickle Cell Disease Treatment
Study: Viking Therapeutics Evaluates VK2809 for Treatment of Non-Alcoholic Steatohepatitis (NASH)
luvqs / Pixabay

Study: Viking Therapeutics Evaluates VK2809 for Treatment of Non-Alcoholic Steatohepatitis (NASH)

  The FDA has recently approved of Viking Therapeutics' Investigational New Drug (IND) application, which allows patients to enroll in their clinical trials. In order to qualify for these trials,…

Continue Reading Study: Viking Therapeutics Evaluates VK2809 for Treatment of Non-Alcoholic Steatohepatitis (NASH)
The Drug Tofacitinib Appears Effective for Juvenile Idiopathic Arthritis in Clinical Trial
source: pixabay.com

The Drug Tofacitinib Appears Effective for Juvenile Idiopathic Arthritis in Clinical Trial

According to a story from Juvenile Arthritis News, the results of a recent phase 3 clinical trial indicate that the drug tofacitinib (marketed as Xeljanz) can be an effective treatment…

Continue Reading The Drug Tofacitinib Appears Effective for Juvenile Idiopathic Arthritis in Clinical Trial
Juvenile Male Patients with von Willebrand Disease More Likely to Experience Complications Than Female Counterparts
source: pixabay.com

Juvenile Male Patients with von Willebrand Disease More Likely to Experience Complications Than Female Counterparts

  The most common inherited bleeding disorder, von Willebrand disease, appears more likely to cause problems for juvenile males living with the disease than juvenile females, according to a study…

Continue Reading Juvenile Male Patients with von Willebrand Disease More Likely to Experience Complications Than Female Counterparts
A Recent Study from Yale Tracks the Progression of Scarring in Idiopathic Pulmonary Fibrosis
source: pixabay.com

A Recent Study from Yale Tracks the Progression of Scarring in Idiopathic Pulmonary Fibrosis

According to a story from EurekAlert!, a collaborative study headed by researchers from Yale University has furthered the understanding of the mechanisms and progression of fibrosis (scarring) in patients with…

Continue Reading A Recent Study from Yale Tracks the Progression of Scarring in Idiopathic Pulmonary Fibrosis
Company Releases Early Clinical Data For Experimental Blood Cancer Drug
SarahMarciano / Pixabay

Company Releases Early Clinical Data For Experimental Blood Cancer Drug

According to a story from pm360online.com, the biopharmaceutical company miRagen Therapeutics, Inc., recently presented Phase I clinical trial data regarding the company's experimental drug cobomarsen. This data was presented at…

Continue Reading Company Releases Early Clinical Data For Experimental Blood Cancer Drug

PID Patients Could Receive More Personalized Treatment Thanks to New Study

A New Study A recent study published in Nature Immunology and conducted by researchers at the University of Basel has produced influential results regarding primary immunodeficiency disorders (PID). These rare disorders…

Continue Reading PID Patients Could Receive More Personalized Treatment Thanks to New Study